You are here

Home

Clinical Trials: Central Nervous System Diseases

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Monday, May 21, 2012 - 12:00
BOTOX® Treatment in Pediatric Upper Limb Spasticity
Conditions:   Pediatrics;   Muscle Spasticity;   Cerebral Palsy;   Stroke
Interventions:   Biological: botulinum toxin Type A;   Biological: botulinum toxin Type A;   Drug: Normal Saline (Placebo)
Sponsor:   Allergan
Recruiting - verified March 2016
Posted: Monday, May 21, 2012 - 12:00
BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity
Conditions:   Pediatrics;   Muscle Spasticity;   Cerebral Palsy;   Stroke
Intervention:   Biological: botulinum toxin Type A
Sponsor:   Allergan
Recruiting - verified March 2016
Posted: Monday, May 21, 2012 - 12:00
BOTOX® Treatment in Pediatric Lower Limb Spasticity
Conditions:   Pediatrics;   Muscle Spasticity;   Cerebral Palsy
Interventions:   Biological: botulinum toxin Type A;   Biological: botulinum toxin Type A;   Drug: Normal Saline (Placebo)
Sponsor:   Allergan
Recruiting - verified March 2016
Posted: Monday, May 21, 2012 - 12:00
BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity
Conditions:   Pediatrics;   Muscle Spasticity;   Cerebral Palsy
Intervention:   Biological: botulinum toxin Type A
Sponsor:   Allergan
Recruiting - verified March 2016
Posted: Wednesday, November 2, 2011 - 12:00
Autologous Bone Marrow Stromal Cell and Endothelial Progenitor Cell Transplantation in Ischemic Stroke
Conditions:   Stroke;   Infarction, Middle Cerebral Artery
Interventions:   Genetic: Autologous BMSCs transplantation;   Genetic: Autologous EPCs transplantation;   Genetic: IV infusion of placebo
Sponsors:   Southern Medical University, China;   The Second People's Hospital of Nanhai District of Foshan;   The First People's Hospital of Haizhu District Guangzhou;   Cellonis Biotechnology Co. Ltd.
Recruiting - verified November 2015
Posted: Tuesday, October 25, 2011 - 12:00
Intravenous Autologous Mesenchymal Stem Cells Transplantation to Treat Middle Cerebral Artery Infarct
Condition:   Middle Cerebral Artery Infarction
Interventions:   Other: Standard medical care;   Biological: Autologous bone marrow-derived mesenchymal stem cells
Sponsors:   National University of Malaysia;   Cytopeutics Sdn Bhd
Recruiting - verified March 2015
Posted: Monday, October 3, 2011 - 12:00
Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients After Stroke
Condition:   Stroke
Intervention:   Procedure: Harvesting and Isolation of Stem Cells
Sponsors:   Ageless Regenerative Institute;   Instituto de Medicina Regenerativa, S.A. de C.V.
Not yet recruiting - verified October 2013
Posted: Monday, October 3, 2011 - 12:00
Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients With Diffuse Lesions in the Brain
Condition:   Brain Lesion (General)
Intervention:   Procedure: harvesting and implantation of adipose derived stem cells
Sponsors:   Ageless Regenerative Institute;   Instituto de Medicina Regenerativa, S.A. de C.V.
Recruiting - verified October 2013
Posted: Monday, October 3, 2011 - 12:00
Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal in Patients With Parkinson's Disease
Condition:   Parkinson's Disease
Intervention:   Procedure: Harvesting and Implantation of Adipose-Derived Stem Cells
Sponsors:   Ageless Regenerative Institute;   Instituto de Medicina Regenerativa, S.A. de C.V.
Recruiting - verified October 2013
Posted: Tuesday, February 16, 2010 - 12:00
Safety and Effectiveness of Cord Blood Stem Cell Infusion for the Treatment of Cerebral Palsy in Children
Condition:   Cerebral Palsy
Interventions:   Biological: Cord Blood Infusion;   Biological: Intravenous Sham
Sponsor:   Georgia Regents University
Recruiting - verified July 2015

Pages